Price $60.80 |
Market Cap
2.29B
|
Sector Health Care |
Div. Growth
-
|
|
P/E
37.0
|
P/B
4.81
|
P/S
4.42
|
Dividend %
-
|
|
P/CF
-
|
P/FCF
22.3
|
Op. Cash Flow
133.4K
|
FCF
2.5
|
|
Op. Margin
14.40%
|
Net Margin
13.00%
|
ROE
15.80%
|
ROI
18.50%
|
|
ROA
8.00%
|
EPS Growth
449.10%
|
Current Ratio
1.2
|
Debt/Equity
12.50%
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| Bausch Health Companies Inc (BHC) | $22.10 | - | - | 8.35B | Strong Buy |
| China Pharma Holdings, Inc. (CPHI) | $0.26 | - | - | 12.3M | Strong Buy |
| Hologic, Inc. (HOLX) | $49.85 | - | - | 13.59B | Strong Buy |
| Biomerica, Inc. (BMRA) | $2.92 | - | - | 33.8M | Strong Buy |
| American Renal Associates Hold (ARA) | $6.64 | - | - | 240.3M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
